HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
Francesca Romana Spinelli, Fabrizio Conti, Massimo Gadina
Abstract
JAK kinase inhibitors are being investigated as a way of managing cytokine storm in severe COVID-19 patients.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyPandemicBiologyMedicineDiseasePathologyOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCytokine Signaling Pathways and InteractionsCOVID-19 Clinical Research Studies